<DOC>
	<DOCNO>NCT00126282</DOCNO>
	<brief_summary>This study examine efficacy medication D-Cycloserine reduction obsession compulsion individual obsessive-compulsive disorder ( OCD ) . All study participant receive Exposure Response Prevention , common form behavior therapy individual OCD . Half ( 50 % ) participant randomly assign placebo condition half ( 50 % ) randomly assign receive D-Cycloserine . Because participant receive 10 session behavior therapy , participant expect improve treatment .</brief_summary>
	<brief_title>A Medication Trial Combined With Behavior Therapy Individuals With Obsessive-compulsive Disorder</brief_title>
	<detailed_description>The study consist Behavior Therapy ( Exposure Response Prevention ; ERP ) OCD . Specifically , involve exposure anxiety-provoking situation response-prevention ritual . ERP show effective many individual OCD . All assessment treatment session cost patient . 50 % patient randomly assign D-Cycloserine ( DCS ) condition , 50 % patient assign placebo condition . D-Cycloserine FDA-approved treatment Tuberculosis . However , recent research anxiety disorder show D-Cycloserine plus Behavior Therapy effective Behavior Therapy alone . This treatment study two active condition . That , patient receive Behavior Therapy expect everybody improve treatment . However , may patient DCS condition improve somewhat placebo condition . The treatment structure homework repeat assessment every 4 week . Assessments extremely important guide treatment provide study investigator necessary information treatment . The treatment consist 10 session ( twice week ) plus post-treatment follow-up assessment 1 6 month .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Compulsive Personality Disorder</mesh_term>
	<mesh_term>Obsessive-Compulsive Disorder</mesh_term>
	<mesh_term>Compulsive Behavior</mesh_term>
	<mesh_term>Cycloserine</mesh_term>
	<criteria>Meets diagnosis obsessivecompulsive disorder History psychotic disorder History neurological disorder History bipolar disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>obsessive-compulsive disorder</keyword>
	<keyword>behavior therapy</keyword>
	<keyword>D-Cycloserine</keyword>
	<keyword>medication</keyword>
	<keyword>treatment trial</keyword>
	<keyword>placebo-controlled</keyword>
	<keyword>double-blind</keyword>
	<keyword>randomize</keyword>
</DOC>